The rate at which the heart deteriorates after Doxo treatment has finished without using any cardioprotective drugs would be well known from other studies. Why do you say it's impossible to know that?
Dr T implies that that rate is higher than the observed decline when using bisantrene in the historical study.
The rate at which the market awards upvotes and GAs makes as much sense as the market's under-valuation or over-valuation of biotech companies.
The rate at which the heart deteriorates after Doxo treatment...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.170(10.9%) |
Mkt cap ! $294.7M | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.73 | $1.57 | $550.9K | 332.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |